Allergy Therapeutics PLC AGYTF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.02
- Day Range
- $0.06–0.06
- 52-Week Range
- $0.01–0.18
- Bid/Ask
- $0.00 / $208,000.00
- Market Cap
- $285.99 Mil
- Volume/Avg
- 5,000 / 5,000
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.54
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 612
Comparables
Valuation
Metric
|
AGYTF
|
DWF
|
NIOX
|
---|---|---|---|
Price/Earnings (Normalized) | — | 8.98 | 16.68 |
Price/Book Value | 8.62 | 7.24 | 3.93 |
Price/Sales | 1.54 | 0.85 | 7.57 |
Price/Cash Flow | — | 6.01 | 22.83 |
Price/Earnings
AGYTF
DWF
NIOX
Financial Strength
Metric
|
AGYTF
|
DWF
|
NIOX
|
---|---|---|---|
Quick Ratio | 0.93 | 1.78 | 3.99 |
Current Ratio | 1.40 | 1.93 | 4.65 |
Interest Coverage | −8.33 | 3.39 | 34.00 |
Quick Ratio
AGYTF
DWF
NIOX
Profitability
Metric
|
AGYTF
|
DWF
|
NIOX
|
---|---|---|---|
Return on Assets (Normalized) | −67.53% | 9.44% | 18.37% |
Return on Equity (Normalized) | −233.81% | 73.80% | 24.61% |
Return on Invested Capital (Normalized) | −105.00% | 15.38% | 20.31% |
Return on Assets
AGYTF
DWF
NIOX
Drug Manufacturers - Specialty & Generic Industry Comparables
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|---|
Zoetis Inc Class A
ZTS
| Hwdmlyytg | Jmhf | $82.1 Bil | |||
Merck KGaA ADR
MKKGY
| Pgxnyxnlcc | Jhqyrk | $75.2 Bil | |||
Haleon PLC ADR
HLN
| Kppldmlq | Pqn | $41.4 Bil | |||
Viatris Inc
VTRS
| Mrbmwyzj | Fywl | $14.4 Bil | |||
Dr Reddy's Laboratories Ltd ADR
RDY
| Lylnjmr | Gchf | $13.7 Bil | |||
Catalent Inc
CTLT
| Gzzqwxmj | Kcqhvh | $10.6 Bil | |||
Perrigo Co PLC
PRGO
| Ggklbdfc | Hdg | $3.8 Bil | |||
Prestige Consumer Healthcare Inc
PBH
| Nkzyrbj | Bljzmzr | $3.5 Bil | |||
Curaleaf Holdings Inc
CURLF
| Glgldpl | Wtlxw | $3.0 Bil | |||
Green Thumb Industries Inc
GTBIF
| Zdpjbbwh | Yktt | $2.7 Bil |